INMUNE BIO INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
INMUNE BIO INC. (INMB) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$550.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2025-03-27
- INMUNE BIO INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2023-12-31 was -$804.00K, a 1024.14% decline year-over-year.
- INMUNE BIO INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2023-09-30 was $78.00K, a 11.36% decline year-over-year.
- INMUNE BIO INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2023-06-30 was $88.00K, a 0.00% change year-over-year.
- INMUNE BIO INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2023-03-31 was $88.00K, a 0.00% change year-over-year.
- INMUNE BIO INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was -$550.00K, a 256.70% decline from fiscal 2022.
- INMUNE BIO INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was $351.00K, a 76.38% increase from fiscal 2021.
- INMUNE BIO INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2021 was $199.00K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$726.00K derived: sum of 2 quarters · filed 2025-03-27 | -$638.00K derived: sum of 3 quarters · filed 2025-03-27 | -$550.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $166.00K derived: sum of 2 quarters · filed 2024-10-31 | $254.00K 10-Q · filed 2024-10-31 | $341.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $176.00K 10-Q · filed 2024-08-01 | $263.00K derived: sum of 3 quarters · filed 2024-08-01 | $351.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $88.00K 10-Q · filed 2024-05-09 | $175.00K derived: sum of 2 quarters · filed 2024-05-09 | $263.00K derived: sum of 3 quarters · filed 2024-05-09 | $351.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $175.00K derived: sum of 2 quarters · filed 2024-03-28 | $263.00K derived: sum of 3 quarters · filed 2024-03-28 | $351.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $176.00K derived: sum of 2 quarters · filed 2023-11-01 | $264.00K 10-Q · filed 2023-11-01 | $352.00K derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $176.00K 10-Q · filed 2023-08-07 | $264.00K derived: sum of 3 quarters · filed 2023-08-07 | $351.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $88.00K 10-Q · filed 2023-05-03 | $176.00K derived: sum of 2 quarters · filed 2023-05-03 | $263.00K derived: sum of 3 quarters · filed 2023-05-03 | |
| 2021-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $175.00K derived: sum of 2 quarters · filed 2023-03-02 | $199.00K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $111.00K 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $24.00K 10-Q · filed 2022-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |